Selected research
Market Structure
Global Bifidobacterium Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bifidobacterium Probiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifidobacterium Probiotics include DuPont(Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Yakult, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bifidobacterium Probiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bifidobacterium Probiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bifidobacterium Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidobacterium Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.
Bifidobacterium Probiotics Segment by Company
DuPont(Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Bifidobacterium Probiotics Segment by Type
Liquid
Powder
Bifidobacterium Probiotics Segment by Application
Food & Beverage
Drugs
Dietary Supplements
Others
Bifidobacterium Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bifidobacterium Probiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bifidobacterium Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bifidobacterium Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bifidobacterium Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
Applications
- Food & Beverage
- Drugs
- Dietary Supplements
- Others
Companies covered
- DuPont(Danisco)
- Chr. Hansen
- Lallemand
- China-Biotics
- Nestle
- Danone
- Probi
- BioGaia
- Yakult
- Novozymes
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bifidobacterium Probiotics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bifidobacterium Probiotics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bifidobacterium Probiotics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bifidobacterium Probiotics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bifidobacterium Probiotics Market Dynamics
- 2.1 Bifidobacterium Probiotics Industry Trends
- 2.2 Bifidobacterium Probiotics Industry Drivers
- 2.3 Bifidobacterium Probiotics Industry Opportunities and Challenges
- 2.4 Bifidobacterium Probiotics Industry Restraints
3 Bifidobacterium Probiotics Market by Manufacturers
- 3.1 Global Bifidobacterium Probiotics Revenue by Manufacturers (2021-2026)
- 3.2 Global Bifidobacterium Probiotics Sales by Manufacturers (2021-2026)
- 3.3 Global Bifidobacterium Probiotics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bifidobacterium Probiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidobacterium Probiotics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bifidobacterium Probiotics Manufacturers, Product Type & Application
- 3.7 Global Bifidobacterium Probiotics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifidobacterium Probiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifidobacterium Probiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Bifidobacterium Probiotics Tier 1, Tier 2, and Tier 3
4 Bifidobacterium Probiotics Market by Type
- 4.1 Bifidobacterium Probiotics Type Introduction
- 4.1.1 Liquid
- 4.1.2 Powder
- 4.2 Global Bifidobacterium Probiotics Sales by Type
- 4.2.1 Global Bifidobacterium Probiotics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bifidobacterium Probiotics Sales by Type (2021-2032)
- 4.2.3 Global Bifidobacterium Probiotics Sales Market Share by Type (2021-2032)
- 4.3 Global Bifidobacterium Probiotics Revenue by Type
- 4.3.1 Global Bifidobacterium Probiotics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bifidobacterium Probiotics Revenue by Type (2021-2032)
- 4.3.3 Global Bifidobacterium Probiotics Revenue Market Share by Type (2021-2032)
5 Bifidobacterium Probiotics Market by Application
- 5.1 Bifidobacterium Probiotics Application Introduction
- 5.1.1 Food & Beverage
- 5.1.2 Drugs
- 5.1.3 Dietary Supplements
- 5.1.4 Others
- 5.2 Global Bifidobacterium Probiotics Sales by Application
- 5.2.1 Global Bifidobacterium Probiotics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bifidobacterium Probiotics Sales by Application (2021-2032)
- 5.2.3 Global Bifidobacterium Probiotics Sales Market Share by Application (2021-2032)
- 5.3 Global Bifidobacterium Probiotics Revenue by Application
- 5.3.1 Global Bifidobacterium Probiotics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bifidobacterium Probiotics Revenue by Application (2021-2032)
- 5.3.3 Global Bifidobacterium Probiotics Revenue Market Share by Application (2021-2032)
6 Global Bifidobacterium Probiotics Sales by Region
- 6.1 Global Bifidobacterium Probiotics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bifidobacterium Probiotics Sales by Region (2021-2032)
- 6.2.1 Global Bifidobacterium Probiotics Sales by Region (2021-2026)
- 6.2.2 Global Bifidobacterium Probiotics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bifidobacterium Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bifidobacterium Probiotics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bifidobacterium Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bifidobacterium Probiotics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bifidobacterium Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bifidobacterium Probiotics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bifidobacterium Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bifidobacterium Probiotics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bifidobacterium Probiotics Revenue by Region
- 7.1 Global Bifidobacterium Probiotics Revenue by Region
- 7.1.1 Global Bifidobacterium Probiotics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bifidobacterium Probiotics Revenue by Region (2021-2026)
- 7.1.3 Global Bifidobacterium Probiotics Revenue by Region (2027-2032)
- 7.1.4 Global Bifidobacterium Probiotics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bifidobacterium Probiotics Revenue (2021-2032)
- 7.2.2 North America Bifidobacterium Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bifidobacterium Probiotics Revenue (2021-2032)
- 7.3.2 Europe Bifidobacterium Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bifidobacterium Probiotics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bifidobacterium Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bifidobacterium Probiotics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bifidobacterium Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DuPont(Danisco)
- 8.1.1 DuPont(Danisco) Company Information
- 8.1.2 DuPont(Danisco) Business Overview
- 8.1.3 DuPont(Danisco) Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DuPont(Danisco) Bifidobacterium Probiotics Product Portfolio
- 8.1.5 DuPont(Danisco) Recent Developments
- 8.2 Chr. Hansen
- 8.2.1 Chr. Hansen Company Information
- 8.2.2 Chr. Hansen Business Overview
- 8.2.3 Chr. Hansen Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Chr. Hansen Bifidobacterium Probiotics Product Portfolio
- 8.2.5 Chr. Hansen Recent Developments
- 8.3 Lallemand
- 8.3.1 Lallemand Company Information
- 8.3.2 Lallemand Business Overview
- 8.3.3 Lallemand Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Lallemand Bifidobacterium Probiotics Product Portfolio
- 8.3.5 Lallemand Recent Developments
- 8.4 China-Biotics
- 8.4.1 China-Biotics Company Information
- 8.4.2 China-Biotics Business Overview
- 8.4.3 China-Biotics Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 China-Biotics Bifidobacterium Probiotics Product Portfolio
- 8.4.5 China-Biotics Recent Developments
- 8.5 Nestle
- 8.5.1 Nestle Company Information
- 8.5.2 Nestle Business Overview
- 8.5.3 Nestle Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Nestle Bifidobacterium Probiotics Product Portfolio
- 8.5.5 Nestle Recent Developments
- 8.6 Danone
- 8.6.1 Danone Company Information
- 8.6.2 Danone Business Overview
- 8.6.3 Danone Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Danone Bifidobacterium Probiotics Product Portfolio
- 8.6.5 Danone Recent Developments
- 8.7 Probi
- 8.7.1 Probi Company Information
- 8.7.2 Probi Business Overview
- 8.7.3 Probi Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Probi Bifidobacterium Probiotics Product Portfolio
- 8.7.5 Probi Recent Developments
- 8.8 BioGaia
- 8.8.1 BioGaia Company Information
- 8.8.2 BioGaia Business Overview
- 8.8.3 BioGaia Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 BioGaia Bifidobacterium Probiotics Product Portfolio
- 8.8.5 BioGaia Recent Developments
- 8.9 Yakult
- 8.9.1 Yakult Company Information
- 8.9.2 Yakult Business Overview
- 8.9.3 Yakult Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Yakult Bifidobacterium Probiotics Product Portfolio
- 8.9.5 Yakult Recent Developments
- 8.10 Novozymes
- 8.10.1 Novozymes Company Information
- 8.10.2 Novozymes Business Overview
- 8.10.3 Novozymes Bifidobacterium Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Novozymes Bifidobacterium Probiotics Product Portfolio
- 8.10.5 Novozymes Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bifidobacterium Probiotics Value Chain Analysis
- 9.1.1 Bifidobacterium Probiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bifidobacterium Probiotics Production Mode & Process
- 9.2 Bifidobacterium Probiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifidobacterium Probiotics Distributors
- 9.2.3 Bifidobacterium Probiotics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst